Search & Read at all times.
Your portable library is online!
3.238.98.39,Hello!
Search Symbol (Half-width) Description of Search Symbols
Space "AND" indicates the intertwining of key terms used in a search
Double Quotation Marks ("") ( " " ) Double quotation marks indicate the beginning and end of a phrase, and the search will only include terms that appear in the same order of those within the quotations. Example: "image process" : " image process "
? Indicates a variable letter. Entering two ? will indicate two variable letters, and so on. Example: "Appl?", search results will yield apple, apply… e , appl y … ( (often used to English word searches) )
* Indicates an unlimited number of variable letters to follow, from 1~n. Example: Enter "appl*", search results will yield apple, apples, apply, applied, application…(often used in English word searches) e , appl es , appl y , appl ied , appl ication … ( (often used to English word searches) )
AND、OR、NOT

Boolean logic combinations of key words is a skill used to expand or refine search parameters.
(1) AND (1) AND: Refines search parameters
(2) OR (2) OR: Expands search parameters (3) NOT: Excludes irrelevant parameters

close

DOI stands for Digital Object Identifier ( D igital O bject I dentifier ) ,
and is the unique identifier for objects on the internet. It can be used to create persistent link and to cite articles.

Using DOI as a persistent link

To create a persistent link, add「http://dx.doi.org/」 「 http://dx.doi.org/ 」 before a DOI.
For instance, if the DOI of an article is 10.5297/ser.1201.002 , you can link persistently to the article by entering the following link in your browser: http://dx.doi.org/ 10.5297/ser.1201.002
The DOI link will always direct you to the most updated article page no matter how the publisher changes the document's position, avoiding errors when engaging in important research.

Cite a document with DOI

When citing references, you should also cite the DOI if the article has one. If your citation guideline does not include DOIs, you may cite the DOI link.

DOIs allow accurate citations, improve academic contents connections, and allow users to gain better experience across different platforms. Currently, there are more than 70 million DOIs registered for academic contents. If you want to understand more about DOI, please visit airiti DOI Registrationdoi.airiti.com ) 。

Close

Reference :

Close

Times Cited : (2)

Abstract

Abstract

Close

What is "Preprint"?

In order to provide readers the forefront academic information, after articles are accepted to publish in the journal, we publish them in network before they're printed. Those "on-line first articles" are called the "preprint articles". The preprint articles do not have volume No., page No., publication date, but can be identified by the DOI number. 「 http://dx.doi.org/ 」 Link to the latest version of the article.

How to cite Preprint Articles?

Please use the online publication date and the DOI number of the preprint article to cite the literature.

Cited example (may vary with different formats you cited):

Author name. Article name. Journal name. YYYY/MM/DD online publish in advance.

doi:DOI Number

Basic Information
Publisher

National Taiwan University

Taiwan

國立臺灣大學 Publishing 』

台大_NTU
2022年
Total2Pages
Previous Page12Next Page
Most Recently Published/Page #
Full-Text Files at the Top
Most Recently Published/Page #
Sort by Ascending Titles
1

IGFBP3透過調控血管增生與缺氧誘導因子的表現趨勢來抑制卵巢上皮細胞癌的侵襲與惡化

施和均

血清類胰島素生長因子結合蛋白-3血小板反應蛋白-1缺氧誘導因子血管新生卵巢癌IGFBP3THBS1HIFsangiogenesisovarian cancer

10.6342/NTU202200857 DOI

Article delay authorization/print view service Full-Text will be available on 2027/06/01

Abstract | Reference(161) Search for full text in Holdings Search for full text in Holdings Track Track

2

上皮性卵巢癌患者腹水YKL-40表現量與臨床預後的關聯性

吳佳穎

卵巢癌YKL-40CHI3L1預後因子腹水ovarian cancerYKL-40CHI3L1prognostic factorascites

10.6342/NTU202201261 DOI

Abstract | Reference(57) Download Download PDF Add to Cart Add to Cart Track Track

3

放射治療與腫瘤免疫反應

陳婉瑜

放射治療溶瘤病毒腫瘤免疫Radiation therapyoncolytic viruscancer immunotherapy

10.6342/NTU202200016 DOI

Abstract | Reference(97) Download Download PDF Add to Cart Add to Cart Track Track

4

非小細胞肺癌之預後因子 – 聚焦於年輕及年老病患以及循環腫瘤細胞

許嘉林

肺癌預後因子年輕病患老年病患循環腫瘤細胞Lung cancerPrognostic factorYoung patientsElderly patientsCirculating tumor cell

10.6342/NTU202200308 DOI

Abstract | Reference(219) Search for full text in Holdings Search for full text in Holdings Unauthorized Unauthorized Track Track

5

注意力不足過動症兒童青少年患者情緒調節困難之相關神經機轉

蔡佳叡

注意力不足過動症情緒調節困難體積形態學分析擴散頻譜影像靜息態功能性磁振造影Attention-Deficit/Hyperactivity Disorder (ADHD)emotion dysregulation (ED)voxel-based morphometry (VBM)diffusion spectrum imaging (DSI)resting-state functional MRI (rsfMRI)

10.6342/NTU202200884 DOI

Abstract | Reference(329) Download Download PDF Add to Cart Add to Cart Track Track

6

尋找克服尿路上皮癌化學治療抗藥性的治療策略──探討組織蛋白去乙醯酶抑制劑及去泛素化酶抑制劑治療之機轉

許富順

尿路上皮癌化學抗藥性克莫抗癌組織蛋白去乙醯酶去泛素化酶Urothelial carcinomachemoresistancecisplatinpaclitaxelhistone deacetylasedeubiquitinating enzymeMAPK pathway

10.6342/NTU202200029 DOI

Abstract | Reference(80) Download Download PDF Add to Cart Add to Cart Track Track

7

B型肝炎帶原接受腎臟移植病患接受免疫抑制劑與抗病毒藥物體內細胞性免疫之動態變化

楊雅雯

B型肝炎病毒腎臟移植肝細胞癌Telbivudine細胞型免疫Hepatitis B virus (HBV)renal transplanthepatocellular carcinomaTelbivudinecellular immunity

10.6342/NTU202200370 DOI

Abstract | Reference(137) Download Download PDF Add to Cart Add to Cart Track Track

8

力弱症對老年健康影響之探究

高東煒

肌肉脂肪肌力力弱症肌少症musclefathandgrip strengthgait speeddynapeniasarcopenia

10.6342/NTU202200474 DOI

Abstract | Reference(164) Download Download PDF Add to Cart Add to Cart Track Track

9

雙孔腹腔鏡手術在子宮附屬器病灶及子宮內膜癌的角色

黃冠儒

單一切口腹腔鏡雙孔腹腔鏡傳統腹腔鏡子宮附屬器手術子宮內膜癌症分期手術single-incision laparoscopic surgerytwo-ports laparoscopic surgeryconventional laparoscopic surgeryadnexa surgeryendometrial cancer surgical staging

10.6342/NTU202200074 DOI

Abstract | Reference(39) Download Download PDF Add to Cart Add to Cart Track Track

10

非小細胞肺癌接受同步化學放射治療的後設分析(meta-analysis)和臨床試驗計畫書

蕭亦秀

肺癌非小細胞肺癌同步放化療免疫療法抑癌寧第三期無法切除肺癌lung cancernon-small cell lung cancerconcurrent chemoradiotherapyimmunotherapydurvalumabstage III unresectable lung cancer

10.6342/NTU202104452 DOI

Abstract | Reference(1) Download Download PDF Add to Cart Add to Cart Track Track

Most Recently Published/Page #
Full-Text Files at the Top
Most Recently Published/Page #
Sort by Ascending Titles
2022年
Total 2 Pages
Previous Page12Next Page

close

close